NetraMark Holdings Inc.
Research NetraMark Holdings Inc. (AIAI) on Bullrun: market cap CAD 63.40M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerAIAI
- ExchangeTO
- CountryCanada
- SectorHealthcare
- IndustryHealth Information Services
- CurrencyCAD
- Market capCAD 63.40M
- Financial periodQ1 2026
- RevenueCAD 10.58K
- Net income-CAD 2.19M
- Free cash flow-CAD 1.34M
Valuation Snapshot
latest market cap is CAD 63.40M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CAD 165.26K | -CAD 5.80M | -CAD 4.74M | n/a | n/a | CAD 871.55K | n/a | CAD 1.18M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-24 | CAD 63.40M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 CAD.
About NetraMark Holdings Inc.
NetraMark Holdings Inc. provides AI-powered insights and software solutions to trial sponsors, clinical research organizations, and biotechnology companies worldwide. It operates NetraAI platform, an advanced machine learning system purpose-built for analyzing complex clinical trial data to identify meaningful patient subpopulations. The company was formerly known as Nurosene Health Inc. and changed its name to NetraMark Holdings Inc. in February 2023. NetraMark Holdings Inc.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is NetraMark Holdings Inc.'s market cap?
NetraMark Holdings Inc.'s market capitalization is CAD 63.40M.
What does NetraMark Holdings Inc. do?
NetraMark Holdings Inc. provides AI-powered insights and software solutions to trial sponsors, clinical research organizations, and biotechnology companies worldwide. It operates NetraAI platform, an advanced machine learning system purpose-built for analyzing complex clinical trial data to identify meaningful patient subpopulations. The company was formerly known as Nurosene Health Inc. and changed its name to NetraMark Holdings Inc. in February 2023. NetraMark Holdings Inc. was founded in 2016 and is headquartered in Toronto, Canada.